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ABSTRACT
To analyze the prevalence and severity of asthma,
rhinitis and eczema in children living in different coun-
tries, the International Study of Asthma and Allergies in
Childhood (ISAAC) was developed. The ISAAC Phase
One study evaluated approximately 720 000 children
in 56 countries, including Japan. In late 1995 and
early 1996, we administered the ISAAC questionnaire
to 4466 schoolchildren aged 13–14 years of age in 
24 schools in Utsunomiya City and Tochigi City (both
in Tochigi Prefecture, Japan). With regard to asthma,
the reported prevalence of wheezing in the preceding
12 months was 8.4%, of frequent wheezing attacks
0.6% and of wheezing with sleep disturbance 0.5%.
The prevalence in the preceding 12 months of rhinitis
was 42.1% and of rhinoconjunctivitis was 21.5%.
Nasal symptoms were most frequent in April (19.9%)
and least frequent in July (5.6%). The prevalence of
atopic eczema in the prior 12 months was 9.6% and
atopic eczema with sleep disturbance was 0.6%. All
prevalence values were slightly increased in Utsunomiya
City, the largest city in Tochigi Prefecture, in compari-
son with Tochigi City. In conclusion, in Japanese cities,
33.3% of children had some allergic symptoms and
2.4% of children reported severe allergic symptoms.
Key words: asthma, childhood, eczema, International
Study of Asthma and Allergies in Childhood, preva-
lence, rhinoconjunctivitis.
INTRODUCTION
Recently, it has been reported that the prevalence of
allergic diseases among children in Japan is increas-
ing.1 Asthma is one of the most important allergic
diseases and has the risk of causing death.2 In addition,
for many children, their activities are limited by asth-
matic attacks, contributing, for instance, to their
absence from school.3 Rhinitis and eczema, while not
causing deaths, affect children, including decreasing
their ability to concentrate on their studies. Although
allergic diseases may cause problems, the prevalence
of allergic diseases in Japanese schoolchildren has not
been determined.
There has also been considerable concern that the
prevalence of asthma and allergic diseases is increasing
in Western and developing countries.4,5 The International
Study of Asthma and Allergies in Childhood (ISAAC)
developed from the merging of two multinational collab-
orative projects (Auckland, New Zealand and Bochum,
Germany), which aimed to analyze these disorders.6,7
In ISAAC Phase One studies, the aims were: (i) to
describe the prevalence and severity of asthma, rhinitis
and eczema in children living in different centers and to
make comparisons within and between countries; (ii) to
obtain baseline measures for the assessment of future
trends in the prevalence and severity of these diseases;
and (iii) to provide a framework for further etiological
research into lifestyle, environmental, genetic and
medical care factors affecting these diseases.8
The Phase One ISAAC evaluations were administered
to approximately 720 000 children in 155 centers of 56
countries between 1994 and 1995.9–12 In Japan, Fukuoka
and Tochigi Prefectures were enrolled in this study. We
report on results of the ISAAC Phase One study per-
formed in Tochigi, Japan.
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METHODS
Subjects
According to the ISAAC protocol, all second-grade junior
high school students (13–14 years of age) in Utsunomiya
City and Tochigi City, including Mibu town, were our
study targets. The ISAAC questionnaires were distributed
in 16 of 22 schools in Utsunomiya City and in eight of
nine schools in Tochigi City via the educational com-
mittee from September 1995 to March 1996 and were
refused by seven schools. The total number of students
sampled was 4466 (3157 students from Utsunomiya City
and 1309 students from Tochigi City).
Study area
Tochigi Prefecture is located 100 km north of Tokyo and
has approximately 2 000 000 inhabitants. Utsunomiya
City is located in the center of Tochigi Prefecture and 
has approximately 440 000 inhabitants and is the largest 
city in Tochigi Prefecture. ‘Utsunomiya’ station of the
Tohoku Shinkansen is in the center of the city and 
the ‘Utsunomiya’ interchange of the Tohoku highway is in
the suburbs. Although there are many inhabitants and
large commercial areas in the center, there are both
industrial areas and farmlands in the suburbs. Utsunomiya
City is a typical large city in the country.
Tochigi City is located in the south of Tochigi Prefecture
and has approximately 85 000 inhabitants, making it the
third largest city in Tochigi Prefecture. There is a small
castle in the town center and the commercial activities are
mainly agriculture. Tochigi City is a typical small city.
Questionnaires
The ISAAC Phase One written questionnaires for 13–14-
year-olds were used (Tables 1–3).7 The questionnaires
were translated into Japanese by our group. The
Japanese questionnaires were translated back to English
by another group, which confirmed that the Japanese
language questionnaires had been correctly translated.
Data analysis
Data were analyzed for the entire group as well as sepa-
rately by gender and by city area (Utsunomiya City or
Tochigi). Percentages and 95% confidence intervals (CI)
of positive responses were calculated.
RESULTS
Observations with missing and inconsistent
data
Among personal information, data were missing or
inconsistent for 599 of 4466 students (13.4%). There
were 341 students (7.6%) with a missing interview date
and these answers were included in the results. There
were 414 students (9.3%) with a missing date of birth, 
61 students (1.4%) with missing values for age and 97
students (2.2%) with inconsistent age and birthdate.
These answers were included in the results, because all
students in the second grade in junior high school are 
13 or 14 years of age under Japanese law. There were
26 students (0.6%) with missing values for sex. These
answers were included in results for the total population
and for analysis by location, but were omitted in analyses
by gender. In answers to questions about allergic symp-
toms, an average of 0.7% (CI 0.2–2.4%) had missing
and inconsistent data.
Prevalence of symptoms of wheezing and
asthma
As shown in Table 1, the percentage of children who had
wheezing in the past was 18.8%, while that of children
who had wheezing in the preceding 12 months was 
8.4% (frequency of mild, moderate and severe wheezing:
5.5, 1.6 and 0.6%, respectively). In comparisons between
Utsunomiya and Tochigi, frequencies of severe wheezing
attacks and sleep disturbances were increased in
Utsunomiya compared with Tochigi. In contrast, the
prevalence of a dry cough was increased in Tochigi. In
comparisons between boys and girls, the frequencies of
each symptom, except exercise-induced wheeze, were
increased in boys compared with girls.
Prevalence of symptoms of rhinitis
The percentage of children who had rhinitis in the past
was 48.5%, while the percentage who had rhinitis or
rhinoconjunctivitis in the past 12 months was 42.1 and
21.5%, respectively (Table 2). The months with the most
prevalent nasal symptoms were April (19.9%) and March
(17.8%), while those with least prevalence were July
(5.6%) and December (6.0%). In comparisons between
Utsunomiya and Tochigi, the prevalences of nasal symp-
toms were increased in Utsunomiya compared with
Tochigi. The prevalences of nasal symptoms between
boys and girls were similar.
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Prevalence of symptoms of eczema
Table 3 presents the prevalence of symptoms of eczema.
The percentage of children who had itchy rash in the pre-
ceding 12 months was 13.0%, while the prevalence of
children who had itchy rash in typical sites for atopic
eczema in the past 12 months was 9.6%. The percentage
of children who had never been cleared of this rash in 
the past 12 months was 3.3% (CI 2.8–3.8%). The per-
centage of eczema symptoms was slightly increased in
Utsunomiya compared with Tochigi. Although the per-
centage of eczema symptoms was increased in girls, the
percentage of severe symptoms with sleep disturbance
did not show any gender differences.
DISCUSSION
Since the ISAAC Phase One was performed in 1995,
results have been published from many countries. In
addition, the ISAAC Steering Committee has published
three worldwide reports,9–12 even though all regional
results were not available. Because we were not able to
complete our analysis before those reports were pub-
lished, our results were not included. Therefore, in the
present report, we compared our results with those for
13–14-year-old children in other countries.
In questionnaires for asthma,9,10 the prevalence values
for asthmatic symptoms within the previous 12 months in
Western Europe and America were approximately 10%
and higher values (above 20%) were present in North
America, Oceania and England. The prevalence values
in Asia and Eastern Europe were approximately 8% and
lower values (under 5%) were found in China, Indonesia
and Russia. Japan is located in Asia-Pacific, for which 
the average prevalence value of asthmatic symptoms was
8.0% and these overall results in Asia-Pacific were very
similar to our results in Japan. These findings suggest
that the prevalence values for asthmatic symptoms 
tend to be high in advanced countries, like North
America and England. Living in an advanced country
may be one risk factor for asthma, although other risk
factors, for example household smoking, air pollution
and foods, may also contribute to the prevalence of asth-
matic symptoms.13–15
For rhinitis, one worldwide report has been published.11
Among the higher prevalence values for rhinitis in the
prior 12 months, Argentina and Paraguay were over
60%. In New Zealand, Australia, Canada, Hong Kong
and Singapore the prevalence rates of rhinitis were
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approximately 40%, frequencies very similar to our results
in Japan. Our evaluated prevalence values for rhinitis
symptoms were in excess of those for asthma and did not
differ in the two geographic areas we studied. In Japan,
it is already known that the percentage of patients with
allergies to pollen is higher than patients with allergies to
house dust or mite.16 In Tochigi Prefecture, with its high
prevalence of rhinoconjunctivitis, there exist the biggest
Japanese cedar-covered mountains in Japan, a major
source of pollen aeroallergens. The seasonality of Japanese
cedar pollen was demonstrated in Tochigi Prefecture in
1995 just before our study (H Yoshida, pers. comm.).
Pollen distribution started on 15 February 1995, peaked
on 28 March and ended on 9 May 1995, as assessed by
the Department of Otorhinolaryngology at Dokkyo
University School of Medicine (Tochigi, Japan). These data
are very similar to the variation in monthly prevalence for
rhinitis observed; in addition, the prevalence of nasal
symptoms in many other countries also increases in the
spring, the season with increased pollen levels. Thus, the
heightened prevalence of rhinoconjunctivitis is likely to be
attributable to environmental exposure to pollen.
In questionnaires for eczema,12 prevalence values for
atopic eczema in the past 12 months in Oceania, Africa,
North America and Western Europe were found to be
11.5, 10.9, 9.1 and 8.8%, respectively, with the highest
values (above 15%) found in Finland and England. In
contrast, lower frequences were reported in Asia (4.3%).
These findings for eczema were very similar to the results
for asthma.
The present study was also performed in Fukuoka
Prefecture, which has one of biggest cities in Japan. In
Fukuoka, the prevalence values for asthmatic and atopic
eczema symptoms in the past 12 months were 13.4 and
10.5%, respectively, and these results were higher than
the results in Tochigi Prefecture. In our results, the preva-
lence values in Utsunomiya city, the biggest city in Tochigi
Prefecture, were higher than those in Tochigi City, sug-
gesting that factors associated with the nature or the scale
of a city contribute to the prevalence of allergic diseases.
This finding suggests that a big city may be a risk factor
for allergic diseases, not only in advanced countries.
Our survey results indicate that 33.3% of children have
allergic symptoms that interfere with their daily activity 
or sleep and 2.4% of children are reported to have 
severe allergic or asthmatic symptoms in Japan. Overall,
49.4% of children did not have any symptoms in the past
12 months. The Japanese Ministry of Education, Science
and Culture has reported that the prevalence of asthma
in schoolchildren has been increasing recently.1 The
ISAAC Phase Three study, to be performed in 2001, plans
to add questions about environments. These questions
may further identify relationships between allergic dis-
eases and environmental exposure.
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